Skip to main content
Terug
Watch Compare

Vaxart, Inc.

Datakwaliteit: 100%
VXRT
OTC Manufacturing Chemicals
€ 0,63
€ 0,00 (0,00%)
Marktkapitalisatie: 152,09 M
Prijs
€ 0,63
Marktkapitalisatie
152,09 M
Dagbereik
52-Weeksbereik
Volume
Openen —
50D / 200D Gem.
50D / 200D Gem.

Quick Summary

Belangrijkste Punten

ROE of 54,76% indicates high profitability
Generating 7,57 M in free cash flow
P/E of 9,32 — trading at a low valuation
Capital efficient — spends only 0,06% of revenue on capex
ROIC of 40,89% — excellent capital efficiency

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)726,68%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
54,76%
Boven sectorgemiddelde (-54,47%)
ROIC40,89%
Net Margin6,88%
Op. Margin7,62%

Veiligheid

Debt / Equity
N/A
Current Ratio0,69
Interest CoverageN/A

Waardering

PE (TTM|NTM)
9,32 | -0,94
Boven sectorgemiddelde (-1,49)
P/B Ratio5,68
EV/EBITDA4,63
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E 9,3 -1,5
P/B 5,7 1,6
ROE % 54,8 -54,5
Net Margin % 6,9 -41,5
Rev Growth 5Y % 1,8
D/E 0,3

Koersdoel Analisten

2 analisten
Buy
Huidig
€ 0,63
+376.2%
Koersdoel
€ 3,00
€ 2,00
€ 3,00
€ 4,00
Vooruitzicht
Forward K/W -0,94
Forward WPA -€ 0,67
Omzet Sch. 1,13 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,67
-€ 0,67 – -€ 0,67
1,13 M 1
FY2026 -€ 0,54
-€ 0,54 – -€ 0,54
355,90 M 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,08 € 0,24 +400,0%
Q32025 -€ 0,07 -€ 0,04 +38,5%
Q22025 -€ 0,10 -€ 0,07 +26,3%
Q12025 -€ 0,07 -€ 0,07 0,0%

Dividend History

1 yr streak
Ex-Date Payment Date Amount Yield
Nov 09, 2012 € 12,19 N/A

All Fundamental Metrics

Growth
Revenue Growth (1Y) 726,68% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 237,26 M Net Income (TTM) 16,33 M
ROE 54,76% ROA 8,75%
Gross Margin N/A Operating Margin 7,62%
Net Margin 6,88% Free Cash Flow (TTM) 7,57 M
ROIC 40,89% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,69
Interest Coverage N/A Asset Turnover 1,27
Working Capital -51,93 M Tangible Book Value 19,24 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years 1 yrs
Valuation
P/E Ratio 9,32 Forward P/E -0,94
P/B Ratio 5,68 P/S Ratio 0,64
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 4,63 Fwd EV/EBITDA N/A
Forward P/S 134,77 Fwd Earnings Yield N/A
FCF Yield 4,98%
Market Cap 152,09 M Enterprise Value 123,29 M
Per Share
EPS (Diluted TTM) 0,07 Revenue / Share 0,98
FCF / Share 0,03 OCF / Share 0,03
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,06% FCF Conversion 46,36%
SBC-Adj. FCF -1,50 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 237,26 M 28,70 M
Net Income 16,33 M -66,95 M -82,47 M -107,76 M -70,47 M
EPS (Diluted) 0,07
Gross Profit
Operating Income 18,07 M -66,29 M -83,35 M -114,59 M -72,75 M
EBITDA
R&D Expenses 201,58 M 74,21 M 68,14 M 81,05 M 48,75 M
SG&A Expenses
D&A 8,58 M 8,85 M 8,62 M 5,81 M 4,21 M
Interest Expense 0,0
Income Tax 476.000,0 260.000,0 261.000,0 67.000,0 107.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 186,08 M 166,39 M 91,83 M 153,85 M 221,17 M
Total Liabilities 98,28 M 107,46 M 34,03 M 43,25 M 33,64 M
Shareholders' Equity 87,80 M 58,93 M 57,81 M 110,60 M 187,53 M
Total Debt
Cash & Equivalents 63,80 M 51,70 M 34,76 M 44,01 M
Current Assets 136,12 M 68,26 M 45,54 M 99,45 M 169,17 M
Current Liabilities 86,75 M 90,88 M 13,72 M 17,92 M 10,78 M